BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+30.72%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$3.11B
AUM Growth
+$3.11B
Cap. Flow
-$232M
Cap. Flow %
-7.45%
Top 10 Hldgs %
51.56%
Holding
91
New
16
Increased
7
Reduced
4
Closed
14

Top Buys

1
SPRY icon
ARS Pharmaceuticals
SPRY
$77.6M
2
LABD icon
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$50.5M
3
CYTK icon
Cytokinetics
CYTK
$43.6M
4
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$42.4M
5
ALGS icon
Aligos Therapeutics
ALGS
$42.2M

Top Sells

1
IMMU
Immunomedics Inc
IMMU
$383M
2
ALLK
Allakos
ALLK
$55M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
$48.8M
4
CGEN icon
Compugen
CGEN
$38.7M
5
QURE icon
uniQure
QURE
$18.6M

Sector Composition

1 Healthcare 96.81%
2 Financials 0.36%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SLDB icon
26
Solid Biosciences
SLDB
$448M
$32.1M 1.03%
4,234,574
+2,702,702
+176% +$20.5M
PAND
27
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$31.3M 1.01%
2,107,513
– –
IDYA icon
28
IDEAYA Biosciences
IDYA
$2.26B
$30.8M 0.99%
2,202,812
– –
AMRN
29
Amarin Corp
AMRN
$311M
$29.3M 0.94%
6,000,000
-1,000,000
-14% -$4.89M
MRNS
30
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$29.3M 0.94%
2,400,000
– –
RNA icon
31
Avidity Biosciences
RNA
$6.13B
$28.6M 0.92%
1,121,327
– –
ANAB icon
32
AnaptysBio
ANAB
$630M
$28M 0.9%
1,300,000
– –
PRVL
33
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$25.9M 0.83%
1,123,105
– –
KDMN
34
DELISTED
Kadmon Holdings, Inc.
KDMN
$25.8M 0.83%
6,205,882
– –
MRUS icon
35
Merus
MRUS
$5.04B
$25M 0.8%
+1,427,849
New +$25M
GOSS icon
36
Gossamer Bio
GOSS
$587M
$24.8M 0.8%
2,562,358
– –
BCAB icon
37
BioAtla
BCAB
$28.7M
$23.3M 0.75%
+686,347
New +$23.3M
CBAY
38
DELISTED
Cymabay Therapeutics
CBAY
$23M 0.74%
4,000,000
– –
MREO
39
Mereo BioPharma
MREO
$275M
$22.3M 0.72%
6,226,673
+2,197,024
+55% +$7.87M
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$11.3B
$21.9M 0.7%
250,000
– –
AKRO icon
41
Akero Therapeutics
AKRO
$3.65B
$21.5M 0.69%
831,495
– –
NGNE icon
42
Neurogene
NGNE
$284M
$21.2M 0.68%
1,501,058
– –
PNT
43
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$20.9M 0.67%
1,500,000
– –
CABA icon
44
Cabaletta Bio
CABA
$144M
$20M 0.64%
1,603,361
+37,000
+2% +$462K
CDAK
45
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$19.5M 0.63%
+602,650
New +$19.5M
CERE
46
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$18.4M 0.59%
+1,314,500
New +$18.4M
CLDX icon
47
Celldex Therapeutics
CLDX
$1.57B
$17.5M 0.56%
1,000,000
– –
MIST icon
48
Milestone Pharmaceuticals
MIST
$151M
$16.6M 0.53%
2,477,194
+700,000
+39% +$4.69M
MTNB icon
49
Matinas BioPharma
MTNB
$10.1M
$15.6M 0.5%
11,478,634
– –
PSTX
50
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$13.7M 0.44%
1,251,055
– –
1
2
3 4